Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, del Giacco S et al (2023) Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper. Eur J Allergy Clin Immunol 78(11):2851–2874. https://doi.org/10.1111/all.15889

Article  CAS  PubMed  Google Scholar 

Khan DA., Knowles SR, Shear NH (2019) Sulfonamide hypersensitivity: fact and fiction. J Allergy Clin Immunol: In Pract 7(7):2116–2123. https://doi.org/10.1016/j.jaip.2019.05.034

Shah TJ, Moshirfar M, Hoopes PC (2018) “Doctor, I have a sulfa allergy”: clarifying the myths of cross-reactivity. Ophthalmology Ther 7(2):211–215. https://doi.org/10.1007/s40123-018-0136-8

Krantz MS, Stone CA, Abreo A, Phillips E (2020) Oral challenge with trimethoprim-sulfamethoxazole in patients with “sulfa” antibiotic allergy. J Allergy Clin Immunol: In Pract 8(2):757–760. https://doi.org/10.1016/j.jaip.2019.07.003

Ovung A, Bhattacharyya J (2021) Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophys Rev 13(2):259–272. https://doi.org/10.1007/s12551-021-00795-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ (2019) Antibiotic allergy. The Lancet 393(10167):183–198. https://doi.org/10.1016/S0140-6736(18)32218-9

Article  Google Scholar 

Shah F, Bell IM (2020) Cutaneous adverse events caused by sulfonamide-containing drugs: reality or perception? J Med Chem 63(14):7447–7457. https://doi.org/10.1021/acs.jmedchem.9b01932

Article  CAS  PubMed  Google Scholar 

Waldron J, Trubiano JA (2022) Antibiotic allergy labels in immunocompromised populations. Transpl Infect Dis 24(5):1–10. https://doi.org/10.1111/tid.13955

Article  Google Scholar 

Moran R, Devchand M, Smibert O, Trubiano JA (2019) Antibiotic allergy labels in hospitalized and critically ill adults: a review of current impacts of inaccurate labeling. Br J Clin Pharmacol 85(3):492–500. https://doi.org/10.1111/bcp.13830

Article  PubMed  PubMed Central  Google Scholar 

Vethody C, Yu R, Keck JM, Onasch MK, Stone CA et al (2021) Safety, efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels. J Allergy Clin Immunol: In Pract 9(2):922–928. https://doi.org/10.1016/j.jaip.2020.09.01

Giles A, Foushee J, Lantz E, Gumina G (2019) Sulfonamide allergies Pharmacy 7(3):132–143. https://doi.org/10.3390/pharmacy7030132

Article  PubMed  Google Scholar 

Chow TG, Khan DA (2022) Sulfonamide hypersensitivity. Clin Rev Allergy Immunol 62(3):400–412. https://doi.org/10.1007/s12016-021-08872-3

Article  CAS  PubMed  Google Scholar 

Prosty C, Copescu AM, Gabrielli S, Mule P, Ben-Shoshan M (2022) Pediatric drug allergy. Immunol Allergy Clin North Am 42(2):433–452. https://doi.org/10.1016/j.iac.2022.01.001

Article  PubMed  Google Scholar 

Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ (2019) Beta-lactam and sulfonamide allergy testing should be a standard of care in immunocompromised hosts. J Allergy Clin Immunol: In Pract 7(7):2151–2153. https://doi.org/10.1016/j.jaip.2019.05.051

Kuyucu S, Mori F, Atanaskovic-Markovic M, Caubet J, Terreehorst I, Gomes E et al (2014) Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review. J Pediatr Allergy Immunol 25:534–543. https://doi.org/10.1111/pai.1227

Asyraf P, Kusnadi I, Stefanus J, Khairinisa M, Abdulah R (2022) Clinical manifestations and genetic influences in sulfonamide-induced hypersentivity. Drug Healthc Patient Saf 14:113–124. https://doi.org/10.2147/DHPS.S347522

Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyyasi S (2021) Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol 77(3):275–289. https://doi.org/10.1007/s00228-020-03005-9

Article  CAS  PubMed  Google Scholar 

Nasim F, Paul JA, Boland-Froemming J, Wylam ME (2021) Sulfa-induced acute eosinophilic pneumonia. Respir Med Case Rep 34:101496. https://doi.org/10.1016/j.rmcr.2021.101496

Article  PubMed  PubMed Central  Google Scholar 

Watanabe Y, Yamaguchi Y (2022) Drug allergy and autoimmune diseases. Allergol Int 71(2):179–184. https://doi.org/10.1016/j.alit.2022.02.001

Article  CAS  PubMed  Google Scholar 

Alzagallaai AA, Sultan EA, Bend JR, Abuzgaia AM, Loubani E, Rieder MJ (2020) Role of oxidative stress in hypersensitivity reactions to sulfonamides. J Clin Pharmacol 60(3):409–421. https://doi.org/10.1002/jcph.1535

Article  CAS  Google Scholar 

Rebelo E, Kuyucu S (2017) Epidemiology and risk factors in drug hypersensitivity reactions. Curr Treat Options Allergy 4:239–257. https://doi.org/10.1007/s40521-017-0128-2

Dorn JM, Alpern M, McNulty C, Volcheck GW (2018) Sulfonamide drug allergy. Curr Allergy Asthma Rep 18(7):38–18. https://doi.org/10.1007/s11882-018-0791-9

Article  PubMed  Google Scholar 

Pratoomwun J, Thomson P, Jaruthamsophon K, Tiyasirichokchai R, Jinda P, Rerkpattanapipat T et al (2021) Characterization of T-cell responses to SMX and XMS-NO in Co-trimoxazole hypersensitivity patients expressing HLA-B*13:01. Front Immunol 12:658593. https://doi.org/10.3389/fimmu.2021.658593

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zambernardi A, Label M (2018) Cutaneous adverse drug reactions: how to identify the trigger. Actas Dermo-Sifiliográficas (English Edition) 109(8):699–707. https://doi.org/10.1016/j.ad.2018.02.017

Article  CAS  Google Scholar 

Pflipsen MC, Vega Colon KM (2020) Anaphylaxis: recognition and management. Am Fam Physician 102(6):355–362

PubMed  Google Scholar 

Dodd A, Hughes A, Sargant N, Whyte AF, Soar J, Turner PJ (2021) Evidence updates for the treatment of anaphylaxis. Resuscitation 163:86–96. https://doi.org/10.1016/j.resuscitation.2021.04.010

Article  PubMed  PubMed Central  Google Scholar 

Navalpakam A, Thanaputkaiporn N, Poowuttikul P (2022) Management of anaphylaxis. Immunol Allergy Clin North Am 42(1):65–76. https://doi.org/10.1016/j.iac.2021.09.005

Banerji A, Solensky R, Phillips EJ, Khan DA (2023) Drug allergy practice parameter updates to incorporate into your clinical practice. J Allergy Clin Immunol: In Pract 11(2):356–368. https://doi.org/10.1016/j.jaip.2022.12.002

Zhang AJ, Nygaard RM, Endorf FW, Hylwa SA (2020) Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective review of 10-year experience. Int J Dermatol 59(2):191–196. https://doi.org/10.1111/ijd.14409

Article  CAS  Google Scholar 

Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA et al (2014) International consensus on drug allergy. Allergy 69(4):420–437. https://doi.org/10.1111/all.12350

Article  CAS  PubMed  Google Scholar 

Pryor J, Olyaei AJ, Kirsch D, Strasfeld L (2019) Sulfonamide desensitization in solid organ transplant recipients: a protocol-driven approach during the index transplant hospitalization. Transpl Infect Dis 21(6):1–15. https://doi.org/10.1111/tid.13191

Article  CAS  Google Scholar 

Negishi S, Miyao K, Ohara F, Motegi K, Wakabayashi H, Yokota H et al (2022) Feasibility of trimethoprim/sulfamethoxazole desensitization therapy in hematological diseases. Adv Online Pub, Clin Exp Med. https://doi.org/10.1007/s10238-022-00868-3

Villarreal-González RV, González-Díaz SN, Canel Paredes A, De Lira-Quezada CE, Rocha-Silva GK, López Méndez A (2022) Management of hypersensitivity to trimethoprim-sulfamethoxazole with an ultrarapid desensitization protocol in HIV infection. J Investig Allergol Clin Immunol 32(1):66–68. https://doi.org/10.18176/jiaci.0708

Khan DA, Banerji A, Blumenthal KG, Phillips EJ, Solensky R, White AA et al (2022) Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol 150(6):1333–1393. https://doi.org/10.1016/j.jaci.2022.08.028

Urbancic KF, Pisasale D, Wight J, Trubiano JA (2018) Dapsone safety in hematology patients: pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients. Transpl Infect Dis 20(6):1–5. https://doi.org/10.1111/tid.12968

Article  CAS  Google Scholar 

Rose M, Vogrin S, Chua KYL, Drewett G, Douglas A, Slavin M (2021) The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy. J Allergy Clin Immunol: In Pract 9(10):3847–3849. https://doi.org/10.1016/j.jaip.2021.05.046

Ramsey A, Rozario C, Stern J (2023) Direct challenges are the gold standard for most antibiotic allergy evaluations. Ann Allergy Asthma Immunol. Adv Online Pub. https://doi.org/10.1016/j.anai.2023.03.033

Wulf NR, Matuszewski KA (2013) Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? Am J Health Syst Pharm 70(17):1483–1494. https://doi.org/10.2146/ajhp/12029

Article  CAS  PubMed  Google Scholar 

Shakoor MT, Ayub S, Ayub Z (2013) Sulfa allergy: cross-reactivity versus multiple concurrent allergies. Am J Infect Dis 9(4):148–154. https://doi.org/10.3844/ajidsp.2013.148.154

Article  CAS  Google Scholar 

Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA et al (2017) The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration. J Allergy Clin Immunolo Pract 5(6):1532–1542. https://doi.org/10.1016/j.jaip.2017.06.017

Ghimire S, Kyung E, Lee JH, Kim JW, Kang W, Kim E (2013) An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. J Clin Pharm Ther 38(3):196–202. https://doi.org/10.1111/jcpt.12048

Article  CAS  PubMed  Google Scholar 

Staffieri P (2020) Cross-reactivity of sulfonamide antibiotics with common sulfa medications. J Nurs Pract 16(2):161–162. https://doi.org/10.1016/j.nurpra.2019.09.014

Hwang TJ, Darge K (2013) Furosemide allergy in children: separating the facts from the myths. Pediatr Radiol 43(10):1409–1410. https://doi.org/10.1007/s00247-013-2761-7

Article  PubMed  Google Scholar